共 62 条
[1]
Das UN(2002)Obesity, metabolic syndrome X, and inflammation Nutrition 18 430-2
[2]
Caiazzo R(2014)Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study Ann Surg 260 893-8
[3]
Tran A(2013)Non-alcoholic steatohepatitis in morbidly obese patients Clin Res Hepatol Gastroenterol 37 17-29
[4]
Gual P(2006)In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease Hepatology 44 27-33
[5]
Wieckowska A(2009)Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study Hepatology 50 1072-8
[6]
Feldstein AE(2013)Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes 2013 839275-24
[7]
Hafeez S(2010)Deciphering the nuclear bile acid receptor FXR paradigm Nucl Recept Signal 8 e005-91
[8]
Ahmed MH(2011)TGR5: a novel target for weight maintenance and glucose metabolism Exp Diabetes Res 2011 853501-64
[9]
Modica S(2013)Bile acid receptors in non-alcoholic fatty liver disease Biochem Pharmacol 86 1517-51
[10]
Gadaleta RM(2013)Human insulin resistance is associated with increased plasma levels of 12alpha-hydroxylated bile acids Diabetes 62 4184-7